BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Attar BM, Moore CM, George M, Ion-Nedelcu N, Turbay R, Zachariah A, Ramadori G, Fareed J, Thiel DHV. Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites. World J Gastroenterol 2014; 20(9): 2374-2382 [PMID: 24605035 DOI: 10.3748/wjg.v20.i9.2374]
URL: https://www.wjgnet.com/1007-9327/full/v20/i9/2374.htm
Number Citing Articles
1
Giuseppe Lippi, Fabian Sanchis-Gomar. Procalcitonin in inflammatory bowel disease: Drawbacks and opportunitiesWorld Journal of Gastroenterology 2017; 23(47): 8283-8290 doi: 10.3748/wjg.v23.i47.8283
2
Lennart Essmann, Yannick Wirz, Claudia Gregoriano, Philipp Schuetz. One biomarker does not fit all: tailoring anti-infective therapy through utilization of procalcitonin and other specific biomarkersExpert Review of Molecular Diagnostics 2023; 23(9): 739 doi: 10.1080/14737159.2023.2242782
3
Emily C. Lydon, Emily R. Ko, Ephraim L. Tsalik. The host response as a tool for infectious disease diagnosis and managementExpert Review of Molecular Diagnostics 2018; 18(8): 723 doi: 10.1080/14737159.2018.1493378
4
Emily R Ko, William E Yang, Micah T McClain, Christopher W Woods, Geoffrey S Ginsburg, Ephraim L Tsalik. What was old is new again: using the host response to diagnose infectious diseaseExpert Review of Molecular Diagnostics 2015; 15(9): 1143 doi: 10.1586/14737159.2015.1059278
5
William E. Yang, Christopher W. Woods, Ephraim L. Tsalik. Current and Emerging Technologies for the Diagnosis of Microbial InfectionsMethods in Microbiology 2015; 42: 465 doi: 10.1016/bs.mim.2015.06.001
6
Ioannis Koutsounas, Garyfallia Kaltsa, Spyros I Siakavellas, Giorgos Bamias. Markers of bacterial translocation in end-stage liver diseaseWorld Journal of Hepatology 2015; 7(20): 2264-2273 doi: 10.4254/wjh.v7.i20.2264
7
Melissa H. Ross, Brittany L. Zick, Ephraim L. Tsalik. Host-Based Diagnostics for Acute Respiratory InfectionsClinical Therapeutics 2019; 41(10): 1923 doi: 10.1016/j.clinthera.2019.06.007
8
Melisa Dirchwolf, Ariel Podhorzer, Monica Marino, Carolina Shulman, Mariano Cartier, Moira Zunino, Silvia Paz, Alberto Muñoz, Andrea Bocassi, Juan Gimenez, Lucía Di Pietro, Gustavo Romero, Hugo Fainboim, Leonardo Fainboim. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severityCytokine 2016; 77: 14 doi: 10.1016/j.cyto.2015.10.006
9
Valeriy D. Lunkov, Marina V. Maevskaya, Ekaterina K. Tsvetaeva, Ana G. Mendez, Maria S. Zharkova, Petr E. Tkachenko, Vladimir T. Ivashkin. Neutrophil to Lymphocyte Ratio as a Predictor of Adverse Outcome in Patients with Decompensated Liver CirrhosisRussian Journal of Gastroenterology, Hepatology, Coloproctology 2019; 29(1): 47 doi: 10.22416/1382-4376-2019-29-1-47-61
10
Giuliano Ramadori. Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and AnticoagulationInternational Journal of Molecular Sciences 2021; 22(13): 7126 doi: 10.3390/ijms22137126
11
Giuseppe Miceli, Grazia Pennisi, Luisa Agnello, Vincenza Calvaruso, Emanuele Amodio, Alessandra Casuccio, Chiara Pintus, Maria Grazia Basso, Rosaria Maria Pipitone, Mario Daidone, Rossella Zito, Giulia Lupo, Salvatore Petta, Giuseppe Cabibbo, Marcello Ciaccio, Stefania Grimaudo, Antonio CraxÌ, Antonino Tuttolomondo. Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin‐22, interleukin‐6 and interleukin‐1Ra concentrations according to portal hypertension and disease severityClinical and Translational Discovery 2023; 3(6) doi: 10.1002/ctd2.215
12
Melisa Dirchwolf, Andrés Eduardo Ruf. Role of systemic inflammation in cirrhosis: From pathogenesis to prognosisWorld Journal of Hepatology 2015; 7(16): 1974-1981 doi: 10.4254/wjh.v7.i16.1974
13
Danai Agiasotelli, Alexandra Alexopoulou, Larisa Vasilieva, Emilia Hadziyannis, Dimitris Goukos, George L. Daikos, Spyros P. Dourakis. High serum lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosisLiver International 2017; 37(4): 576 doi: 10.1111/liv.13264
14
Melissa Ross, Ricardo Henao, Thomas W. Burke, Emily R. Ko, Micah T. McClain, Geoffrey S. Ginsburg, Christopher W. Woods, Ephraim L. Tsalik, José Moreira. A comparison of host response strategies to distinguish bacterial and viral infectionPLOS ONE 2021; 16(12): e0261385 doi: 10.1371/journal.pone.0261385
15
M. R. Sarkarova, M. V. Maevskaya. Prognostic and diagnostic value of the ratio of neutrophils to lymphocytes of patients with diseases of the gastrointestinal tract and liverMeditsinskiy sovet = Medical Council 2022; (7): 60 doi: 10.21518/2079-701X-2022-16-7-60-68
16
Michael Meisner. Update on Procalcitonin MeasurementsAnnals of Laboratory Medicine 2014; 34(4): 263 doi: 10.3343/alm.2014.34.4.263
17
Kundan Kumar, Samir Mohindra, Mithun Raj, Gourdas Choudhuri. Procalcitonin as a marker of sepsis in alcoholic hepatitisHepatology International 2014; 8(3): 436 doi: 10.1007/s12072-014-9540-x
18
H. Fukui. Liver Pathophysiology2017; : 341 doi: 10.1016/B978-0-12-804274-8.00027-8
19
Selina Wolfisberg, Claudia Gregoriano, Philipp Schuetz. Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19Critical Reviews in Clinical Laboratory Sciences 2022; 59(1): 54 doi: 10.1080/10408363.2021.1975637
20
Francesca Romana Ponziani, Maria Assunta Zocco, Lucia Cerrito, Antonio Gasbarrini, Maurizio Pompili. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implicationsExpert Review of Gastroenterology & Hepatology 2018; 12(7): 641 doi: 10.1080/17474124.2018.1481747
21
María Martínez-Esparza, María Tristán-Manzano, Antonio J Ruiz-Alcaraz, Pilar García-Peñarrubia. Inflammatory status in human hepatic cirrhosisWorld Journal of Gastroenterology 2015; 21(41): 11522-11541 doi: 10.3748/wjg.v21.i41.11522
22
M. R. Sarkarova, M. V. Maevskaya. Prognostic value of the neutrophil to lymphocyte ratio in the clinical course of liver cirrhosisMeditsinskiy sovet = Medical Council 2024; (8): 66 doi: 10.21518/ms2024-187
23
Georgios I Tsiaoussis, Stelios F Assimakopoulos, Athanassios C Tsamandas, Christos K Triantos, Konstantinos C Thomopoulos. Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implicationsWorld Journal of Hepatology 2015; 7(17): 2058-2068 doi: 10.4254/wjh.v7.i17.2058
24
Shubhra MISHRA, Sant RAM, Kaushal K PRASAD, Arun K SHARMA, Usha DUTTA, Vishal SHARMA. SERUM PROCALCITONIN AS A PROGNOSTIC MARKER IN ACUTE SEVERE ULCERATIVE COLITIS: A PROSPECTIVE STUDYArquivos de Gastroenterologia 2022; 59(1): 75 doi: 10.1590/s0004-2803.202200001-14
25
Pushpa Yadav, Nirupama Trehanpati, Rakhi Maiwall, Rashi Sehgal, Ravinder Singh, Mojahidul Islam, Rakesh Kumar Jagdish, Rajan Vijayaraghavan, Deepanshu Maheshwari, Sadam Bhat, Pratibha Kale, Anupam Kumar, Sukriti Baweja, Guresh Kumar, Gayatri Ramakrishna, Shiv K. Sarin. Soluble factors and suppressive monocytes can predict early development of sepsis in acute‐on‐chronic liver failureHepatology Communications 2022; 6(8): 2105 doi: 10.1002/hep4.1949
26
Christa Buechler, Elisabeth Haberl, Lisa Rein-Fischboeck, Charalampos Aslanidis. Adipokines in Liver CirrhosisInternational Journal of Molecular Sciences 2017; 18(7): 1392 doi: 10.3390/ijms18071392
27
M. R. Sarkarova, M. V. Maevskaya. Prognostic value of the neutrophil to lymphocyte ratio in the development of systemic inflammatory response syndrome and death in patients with liver cirrhosisMeditsinskiy sovet = Medical Council 2024; (15): 104 doi: 10.21518/ms2024-337